Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.87 USD | -4.45% | -3.51% | -38.77% |
May. 15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
May. 14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
Evolution of the average Target Price on Fennec Pharmaceuticals Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Fennec Pharmaceuticals Inc.
HC Wainwright | |
Cantor Fitzgerald | |
Wedbush | |
Maxim | |
Capital One Securities | |
Craig-Hallum |
EPS Revisions
- Stock Market
- Equities
- FENC Stock
- Consensus Fennec Pharmaceuticals Inc.